Anna Kidwell is currently the Director of Commercial Development in Oncology at Pfizer, a position they began in 2024. Previously, Anna held the role of Global Market Insights Lead for Tucatinib at Seagen until its acquisition by Pfizer in December 2023, alongside serving as the Founding Co-Chair of the Women's Impact Network. Their extensive experience in the pharmaceutical industry includes various marketing and research roles at Eli Lilly and Company, where they received multiple awards for excellence in market research and marketing. Anna's educational background includes ongoing studies for a Master's degree at the University of Georgia's Terry College of Business, as well as Bachelor's degrees from Louisiana Tech University.
This person is not in any teams
This person is not in any offices